HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Qu, S. J. Articles by Pownall, H. J. Search for Related Content PubMed PubMed Citation Articles by Qu, S. J. Articles by Pownall, H. J. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 36, 967-974, Copyright © 1995 by Lipid Research, Inc.

ARTICLES

In vitro expression of natural mutants of human lecithin:cholesterol acyltransferase

SJ Qu, HZ Fan, F Blanco-Vaca and HJ Pownall
Department of Medicine, Baylor College of Medicine, Houston, TX, USA.

Fish-eye disease (FED) and familial lecithin:cholesterol acyltransferase (LCAT) deficiency (FLD) are rare disorders of lipid metabolism linked to mutations in the LCAT gene. Eleven LCAT cDNA constructs associated with FED and FLD were prepared by site-directed mutagenesis and expressed in COS-6 cells. Analysis of total RNA from wild-type, FED, and FLD transfectants revealed that all contained LCAT- specific mRNA. Western blot analysis demonstrated that all LCAT transfectants synthesized LCAT. Mean LCAT secretion by FED transfectants was slightly lower than secretion by wild-type transfectants, whereas secretion by FLD transfectants was much lower. The specific activities of FED and FLD LCAT against model high density lipoproteins were 6% and 11%, respectively, of wild-type activity. The ratios of the LCAT activities against low density lipoproteins to those against model high density lipoproteins decreased in the order FED mutants > FLD mutants approximately wild type. FED and FLD LCAT mutants are different: the former are more active against low density lipoproteins, and the latter are less secretion-competent. The greater reactivity of FED LCAT against low density lipoproteins may explain the relative mildness of the clinical manifestations of FED compared to those of FLD.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				V. Charlton-Menys, L. Pisciotta, P. N. Durrington, R. Neary, C. D. Short, L. Calabresi, S. Calandra, and S. Bertolini Molecular characterization of two patients with severe LCAT deficiency Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2379 - 2382. [Full Text] [PDF]

				F. Peelman, J-L. Verschelde, B. Vanloo, C. Ampe, C. Labeur, J. Tavernier, J. Vandekerckhove, and M. Rosseneu Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity J. Lipid Res., January 1, 1999; 40(1): 59 - 69. [Abstract] [Full Text]

				S. Adimoolam, L. Jin, E. Grabbe, J.-J. Shieh, and A. Jonas Structural and Functional Properties of Two Mutants of Lecithin-Cholesterol Acyltransferase (T123I and N228K) J. Biol. Chem., December 4, 1998; 273(49): 32561 - 32567. [Abstract] [Full Text] [PDF]

				F. Blanco-Vaca, S.-J. Qu, C. Fiol, H.-Z. Fan, Q. Pao, A. Marzal-Casacuberta, J. J. Albers, I. Hurtado, V. Gracia, X. Pinto, et al. Molecular Basis of Fish-Eye Disease in a Patient From Spain : Characterization of a Novel Mutation in the LCAT Gene and Lipid Analysis of the Cornea Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1382 - 1391. [Abstract] [Full Text]

				L. Krimbou, M. Marcil, J. Davignon, and J. Genest Jr. Interaction of Lecithin:Cholesterol Acyltransferase (LCAT){middle dot}alpha 2-Macroglobulin Complex with Low Density Lipoprotein Receptor-related Protein (LRP). EVIDENCE FOR AN alpha 2-MACROGLOBULIN/LRP RECEPTOR-MEDIATED SYSTEM PARTICIPATING IN LCAT CLEARANCE J. Biol. Chem., August 24, 2001; 276(35): 33241 - 33248. [Abstract] [Full Text] [PDF]